STOCKHOLM, SWEDEN / November 20, 2023 / At this year’s RSNA in Chicago, November 26-30, ContextVision puts their success story Altumira in the spotlight — adding new, impressive features to an already exceptional image enhancement solution.
ContextVision offers solutions for ultrasound, X-ray and MRI. With a core business focus on image enhancement software designed to deliver unprecedented image quality, ContextVision is the global market leader and partner to leading OEMs, with solutions installed worldwide in more than 450,000 systems. Thanks to its superior imaging quality, ContextVision’s technology leads to more rapid and confident diagnoses.
One of ContextVision’s most successful solutions is Altumira, a powerful software that draws on advanced AI to take digital X-ray images to a whole new level. Designed to address the many challenges of static and dynamic digital radiography, Altumira combines ContextVision’s world-leading image enhancement technology with the latest breakthroughs in deep learning.
This year’s RSNA sees the unveiling of updated versions of Altumira and Altumira Plus
Altumira now features impressive scatter correction functionality, for exceptional quality in images acquired without a physical grid. Powered by AI, the scatter correction feature offers flexible and efficient contrast, detail, and noise control. This in turn enables improved workflow, enhanced efficiency, and a lower X-ray dose compared to images acquired with a grid.
Altumira Plus — for dynamic imaging — will be upgraded with improved noise suppression and enhanced visualization of details, e.g., stents and vessels. These new features add value to interventional cardiovascular procedures performed with mobile c-arms and angiography systems.
Meet ContextVision at RSNA in booth #6802
ContextVision will be demonstrating the new Altumira features at RSNA 2023. Join them at Booth #6802, North Hall, Level 3. For more info, contact William McGinnis, Sales Director Americas, or visit www.contextvision.com.
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence
for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities
Trading Act. This information is inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act.